These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23823925)

  • 1. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity.
    Tsakova AD; Gateva AT; Kamenov ZA
    Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
    Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
    Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
    Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
    Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.
    Mahmoudi T; Gourabi H; Ashrafi M; Yazdi RS; Ezabadi Z
    Fertil Steril; 2010 Mar; 93(4):1208-14. PubMed ID: 19230880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
    Velija-Ašimi Z
    Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
    Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E
    Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
    Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
    Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
    Kozakowski J; Kapuścińska R; Zgliczyński W
    Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
    Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
    Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
    Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.